Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Pharma Industry News Bone Biologics files new U.S. patent for NELL-1-based bone regeneration in spinal fusion Bone Biologics files U.S. patent for rhNELL-1 bone regeneration in spine fusion, expanding IP ahead of clinical development. Learn what it means for investors. byPallavi MadhirajuJune 30, 2025